Blepharospasm News and Research

RSS
Salk researchers develop new computer program to measure blepharosplasm severity

Salk researchers develop new computer program to measure blepharosplasm severity

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

Updated guidance on botulinum toxin formulations for four indications

Updated guidance on botulinum toxin formulations for four indications

AAN’s updated guideline on botulinum toxin use covers four neurologic disorders

AAN’s updated guideline on botulinum toxin use covers four neurologic disorders

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

Merz presents XEOMIN clinical data on dystonia at IDS 2011

Merz presents XEOMIN clinical data on dystonia at IDS 2011

Merz launches 'Make Your Mark' campaign to raise awareness on cervical dystonia

Merz launches 'Make Your Mark' campaign to raise awareness on cervical dystonia

Merz introduces new educational website for patients with focal dystonias

Merz introduces new educational website for patients with focal dystonias

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Botox receives FDA approval for treatment of chronic migraine

Botox receives FDA approval for treatment of chronic migraine

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

Dietary supplement combining zinc, phytase enhances effectiveness of BTX injections: Study

Dietary supplement combining zinc, phytase enhances effectiveness of BTX injections: Study

Xeomin receives FDA approval for treatment of cervical dystonia

Xeomin receives FDA approval for treatment of cervical dystonia

Allergan celebrates 20th anniversary of BOTOX in Canada

Allergan celebrates 20th anniversary of BOTOX in Canada

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

FDA issues complete response letter to Ipsen for Dysport BLA

FDA issues complete response letter to Ipsen for Dysport BLA

'Eyes tight shut case' confounds experts

'Eyes tight shut case' confounds experts

New guidelines say botulinum toxin effective for many neurological disorders, but not headache

New guidelines say botulinum toxin effective for many neurological disorders, but not headache